Full Name
Kesavan Esuvaranathan
Variants
Esuvaranathan, K.
Kesavan, E.
 
Main Affiliation
 
 
Email
suresuva@nus.edu.sg
 

Publications

Refined By:
Author:  Mahendran, Ratha

Results 1-16 of 16 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
112-Jan-2017A murine orthotopic bladder tumor model and tumor detection systemTham S.M. ; Esuvaranathan K. ; Mahendran R. 
211-Apr-2018Bacillus Calmette-Guerin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survivalRahmat, Juwita N ; Esuvaranathan, Kesavan ; Mahendran, Ratha 
31-Jul-2016Beyond diabetes: The role of metformin in non-muscle invasive bladder cancerWang, Ziting; Chiong, Edmund ; Kesavan, Esuvaranathan ; Sng, Jen-Hwei ; Mahendran, Ratha ; Ong, Wilson; Shen, Tong 
41999Evaluation of lymphocytic responses after treatment with bacillus Calmette-Guerin and interferon-α 2b for superficial bladder cancerGan, Y.-H. ; Mahendran, R. ; Lawrencia, C.; Esuvaranathan, K. ; James, K.
52007Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic.Pook, S.H. ; Rahmat, J.N.; Esuvaranathan, K. ; Mahendran, R. 
625-Nov-2021Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyowith GMCSF + IFNa Induce Systemic Immunity in a MurineOrthotopic Bladder Cancer ModelTham, Sin Mun ; Rahmat, Juwita ; Chiong, Edmund ; Wu, Qing Hui ; Esuvaranathan, Kesavan ; Mahendran, Ratha 
72016Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer TherapyAng, W.X; Zhao, Y; Kwang, T; Wu, C; Chen, C; Toh, H.C; Mahendran, R ; Esuvaranathan, K ; Wang, S 
82004Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporterWu, Q. ; Esuvaranathan, K. ; Mahendran, R. 
92002N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cellsPook, S.H. ; Esuvaranathan, K. ; Mahendran, R. 
102004Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.Zang, Z. ; Mahendran, R. ; Wu, Q. ; Yong, T.; Esuvaranathan, K. 
112003Nonviral cytokine gene therapy on an orthotopic bladder cancer modelWu, Q. ; Mahendran, R. ; Esuvaranathan, K. 
122007Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alphaEsuvaranathan, K. ; Chiong, E. ; Kamaraj, R.; Mahendran, R. ; Thamboo, T.P. ; Teh, M.; Chan, Y.H.
132007Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alphaEsuvaranathan, K. ; Chiong, E. ; Kamaraj, R.; Mahendran, R. ; Thamboo, T.P. ; Teh, M. ; Chan, Y.H.
142002The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cellsZhang, Y. ; Yap, L.L. ; Khoo, H.E. ; Mahendran, R. ; Esuvaranathan, K. 
152001Transfection of urothelial cells using methyl-β-cyclodextrin solubilized cholesterol and DotapLawrencia, C. ; Mahendran, R. ; Esuvaranathan, K. 
167-Apr-2022Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic-Chemotherapy of Orthotopic Bladder CancerSun, Bowen; Bte Rahmat, Juwita Norasmara ; Kim, Han Joon ; Mahendran, Ratha ; Esuvaranathan, Kesavan ; Chiong, Edmund ; Ho, John S; Neoh, Koon Gee ; Zhang, Yong